NASDAQ$ABSI
Absci Corp · Q3 2025 earnings
Q3 2025 earnings · · After market close · Investor relations
Briefing
Absci reported Q3 2025, a net loss of $28.7M.
For Q3 2025, Absci reported a net loss of $28.7M. Management discussed operating trends, liquidity, and priorities as disclosed in the quarterly filing.
- Net loss $28.7M.
- Absci updated strategic and capital priorities in the filing.
- Absci updated strategic and capital priorities in the filing.
Headline financials
Revenue & EPS history
Absci · Revenue · Quarterly
$378K
Forward guidance
The filing discusses Absci's outlook, capital deployment, and key risks without relying solely on numeric EPS guidance.
Tailwinds
- Absci cited execution on strategic priorities in the filing.
- Balance sheet and liquidity support continued operations.
- Pipeline milestones remain the primary value driver.
Headwinds
- GAAP profitability remained under pressure in the quarter.
- Macro, competitive, and cost pressures may affect margins.
- Segment mix and one-time items can affect comparability.
- Clinical-stage spend continues ahead of commercial revenue.
Historical earnings impact
How earnings announcements have historically affected this stock's price.
Avg. return before/after earnings
Based on 19 quarterly earnings reports · overlaid with Q3 2025
-9.1%
Avg return
Earnings day
-9.1%
Avg return
5 days after
-9.3%
Avg return
30 days after
21%
5 / 24 earnings
Positive
+13.8%
Q2 2022
Best reaction
-28.9%
Q4 2020
Worst reaction
| Quarter | Report date | Reaction (Day 0) | +5 days | +30 days |
|---|---|---|---|---|
| Q4 2025 | -5.6% | +8.6% | — | |
| Q1 2026 | -3.4% | -10.1% | +7.1% | |
| Q3 2025 | -22.4% | -16.5% | +7.1% | |
| Q2 2025 | +5.1% | -4.7% | -14.1% | |
| Q1 2025 | -0.7% | -6.4% | -6.1% | |
| Q4 2024 | -3.2% | +0.6% | +0.3% | |
| Q3 2024 | -26.6% | -33.6% | -14.0% | |
| Q2 2024 | +6.7% | +7.5% | +0.5% | |
| Q1 2024 | -4.5% | -8.8% | -13.6% | |
| Q4 2023 | -2.8% | +2.4% | -6.3% | |
| Q3 2023 | +12.0% | +16.0% | +120.8% | |
| Q2 2023 | -2.4% | +0.0% | -1.2% | |
| Q1 2023 | -6.4% | +11.2% | +34.4% | |
| Q4 2022 | -0.8% | -0.3% | -25.2% | |
| Q3 2022 | -0.3% | +1.6% | -14.7% | |
| Q2 2022 | +13.8% | +9.0% | -1.4% | |
| Q1 2022 | -11.3% | -9.0% | -21.7% | |
| Q4 2021 | +7.2% | +9.6% | +3.8% | |
| Q3 2021 | -28.5% | -38.0% | -41.4% | |
| Q3 2020 | -28.5% | -38.0% | -41.4% | |
| Q1 2021 | -28.9% | -30.1% | -46.4% | |
| Q2 2021 | -28.9% | -30.1% | -46.4% | |
| Q2 2020 | -28.9% | -30.1% | -46.4% | |
| Q4 2020 | -28.9% | -30.1% | -46.4% | |
| Q1 2020 | — | — | — |
Discussion
Share your read of this quarter. Sign-in carries your eToro identity.
Join the conversation
Sign in with eToro to post your read of this quarter and vote on others'.
Sign in with eToro